About Us
Chongqing Biomean Technology Co., Ltd. is a professional biotechnology company that adheres to the development philosophy of "openness, cooperation, and mutual benefit". The company specializes in the research, development, and production of in vitro diagnostic reagent raw materials and provides comprehensive reagent solutions. Its main products, based on genetic engineering technology, include recombinant antigens, antibodies, molecular diagnostic raw materials, and diagnostic reagent solutions. These products have reached or even exceeded international advanced levels in some areas. In recent years, Biomean has actively expanded its business both domestically and internationally, providing high-quality products and professional technical services to hundreds of customers at home and abroad. Its products have been used by domestic and international manufacturers for registration and large-scale sales of diagnostic products. As a leading supplier of key raw materials and reagent solutions in the in vitro diagnostics industry, we continuously provide high-quality products and technical services to the domestic and international diagnostics industry, contributing to the development of precision medicine.
Our core technology and management team have years of experience in the research, development, and production management of clinical diagnostic immunological and molecular materials. We possess unique diagnostic material design technology, proprietary efficient expression systems, and advanced preparation techniques such as the construction of high-efficiency fusion, super-large-capacity human, sheep, rabbit, and chicken recombinant antibody libraries, high-activity enzyme screening, and large-scale production. We offer comprehensive solutions in enzyme-linked immunosorbent assay (ELISA), immunochromatography, chemiluminescence, immunoturbidimetry, and efficient nucleic acid isothermal amplification reagents. In 2017, we became the Chongqing Diagnostic Antibody Engineering Technology Research Center; in 2020, we were approved as a Chongqing independent legal entity new enterprise R&D institution, passed the national high-tech enterprise certification and ISO9001 quality system certification; in 2022, we were recognized as a "specialized, refined, and new" enterprise in Chongqing, and as a large-scale enterprise in the Chongqing Liangjiang New Area;in 2024, we passed the ISO13485 quality system certification.
